Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study to Assess the Feasibility of Gleolan (ALA / Aminolevulinic Acid HCl) in Pediatric Brain Tumor Patients After Delayed Administration

NCT06907485 is registered in ClinicalTrials.gov with Costas Hadjipanayis as lead sponsor.

NCT NCT06907485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06907485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study to Assess the Feasibility of Gleolan (ALA / Aminolevulinic Acid HCl) in Pediatric Brain Tumor Patients After Delayed Administration
Lead sponsor
Costas Hadjipanayis
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 31, 2027
Completion date
August 31, 2029
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric brain tumor